1. Apostolakis S, Baritaki S, Kochiadakis GE, Igoumenidis NE, Panutsopulos D, Spandidos DA. (2007) Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease.
Thromb Res, 119 (1): 63-71.
[PMID:16480760]
2. Brand S, Hofbauer K, Dambacher J, Schnitzler F, Staudinger T, Pfennig S, Seiderer J, Tillack C, Konrad A, Göke B et al.. (2006) Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
Am J Gastroenterol, 101 (1): 99-106.
[PMID:16405540]
3. Brumme ZL, Dong WW, Chan KJ, Hogg RS, Montaner JS, O'Shaughnessy MV, Harrigan PR. (2003) Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response.
AIDS, 17 (2): 201-8.
[PMID:12545080]
4. Chan CC, Tuo J, Bojanowski CM, Csaky KG, Green WR. (2005) Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration.
Histol Histopathol, 20: 857-863.
[PMID:15944936]
5. Combadiere C, Ahuja SK, Murphy PM. (1995) Cloning, chromosomal localization, and RNA expression of a human beta chemokine receptor-like gene.
DNA Cell Biol, 14: 673-680.
[PMID:7646814]
6. Combadiere C, Gao J, Tiffany HL, Murphy PM. (1998) Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine.
Biochem Biophys Res Commun, 253 (3): 728-32.
[PMID:9918795]
7. Combadiere C, Salzwedel K, Smith ED, Tiffany HL, Berger EA, Murphy PM. (1998) Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1.
J Biol Chem, 273: 23799-23804.
[PMID:9726990]
8. Combadière C, Potteaux S, Gao JL, Esposito B, Casanova S, Lee EJ, Debré P, Tedgui A, Murphy PM, Mallat Z. (2003) Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.
Circulation, 107 (7): 1009-16.
[PMID:12600915]
9. Damås JK, Boullier A, Waehre T, Smith C, Sandberg WJ, Green S, Aukrust P, Quehenberger O. (2005) Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy.
Arterioscler Thromb Vasc Biol, 25 (12): 2567-72.
[PMID:16224053]
10. Daoudi M, Lavergne E, Garin A, Tarantino N, Debré P, Pincet F, Combadière C, Deterre P. (2004) Enhanced adhesive capacities of the naturally occurring Ile249-Met280 variant of the chemokine receptor CX3CR1.
J Biol Chem, 279 (19): 19649-57.
[PMID:14990582]
11. Faure S, Meyer L, Costagliola D, Vaneensberghe C, Genin E, Autran B, Delfraissy JF, McDermott DH, Murphy PM, Debré P et al.. (2000) Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.
Science, 287 (5461): 2274-7.
[PMID:10731151]
12. Garin A, Tarantino N, Faure S, Daoudi M, Lécureuil C, Bourdais A, Debré P, Deterre P, Combadiere C. (2003) Two novel fully functional isoforms of CX3CR1 are potent HIV coreceptors.
J Immunol, 171 (10): 5305-12.
[PMID:14607932]
13. Ghilardi G, Biondi ML, Turri O, Guagnellini E, Scorza R. (2004) Internal carotid artery occlusive disease and polymorphisms of fractalkine receptor CX3CR1: a genetic risk factor.
Stroke, 35 (6): 1276-9.
[PMID:15118174]
14. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ et al.. (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.
Cell, 91 (4): 521-30.
[PMID:9390561]
15. Jiang Y, Salafranca MN, Adhikari S, Xia Y, Feng L, Sonntag MK, deFiebre CM, Pennell NA, Streit WJ, Harrison JK. (1998) Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis.
J Neuroimmunol, 86 (1): 1-12.
[PMID:9655467]
16. Lavergne E, Labreuche J, Daoudi M, Debré P, Cambien F, Deterre P, Amarenco P, Combadière C, GENIC Investigators. (2005) Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease.
Arterioscler Thromb Vasc Biol, 25 (4): 847-53.
[PMID:15681302]
17. Lesnik P, Haskell CA, Charo IF. (2003) Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.
J Clin Invest, 111 (3): 333-40.
[PMID:12569158]
18. McDermott DH, Fong AM, Yang Q, Sechler JM, Cupples LA, Merrell MN, Wilson PW, D'Agostino RB, O'Donnell CJ, Patel DD, Murphy PM. (2003) Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.
J Clin Invest, 111: 1241-1250.
[PMID:12697743]
19. McDermott DH, Halcox JP, Schenke WH, Waclawiw MA, Merrell MN, Epstein N, Quyyumi AA, Murphy PM. (2001) Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.
Circ Res, 89 (5): 401-7.
[PMID:11532900]
20. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ. (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity.
Proc Natl Acad Sci USA, 95 (24): 14500-5.
[PMID:9826729]
21. Moatti D, Faure S, Fumeron F, Amara Mel-W, Seknadji P, McDermott DH, Debré P, Aumont MC, Murphy PM, de Prost D et al.. (2001) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.
Blood, 97 (7): 1925-8.
[PMID:11264153]
22. Niessner A, Marculescu R, Haschemi A, Endler G, Zorn G, Weyand CM, Maurer G, Mannhalter C, Wojta J, Wagner O et al.. (2005) Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
Thromb Haemost, 93 (5): 949-54.
[PMID:15886814]
23. Nishiyori A, Minami M, Ohtani Y, Takami S, Yamamoto J, Kawaguchi N, Kume T, Akaike A, Satoh M. (1998) Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia?.
FEBS Lett, 429 (2): 167-72.
[PMID:9650583]
24. Oh SB, Endoh T, Simen AA, Ren D, Miller RJ. (2002) Regulation of calcium currents by chemokines and their receptors.
J Neuroimmunol, 123 (1-2): 66-75.
[PMID:11880151]
25. Raport CJ, Schweickart VL, Eddy RL, Shows TB, Gray PW. (1995) The orphan G-protein-coupled receptor-encoding gene V28 is closely related to genes for chemokine receptors and is expressed in lymphoid and neural tissues.
Gene, 163: 295-299.
[PMID:7590284]
26. Sbrana S, Bevilacqua S, Buffa M, Spiller D, Parri MS, Gianetti J, De Filippis R, Clerico A. (2005) Post-reperfusion changes of monocyte function in coronary blood after extracorporeal circulation.
Cytometry B Clin Cytom, 65 (1): 14-21.
[PMID:15786508]
27. Shen F, Zhang Y, Jernigan DL, Feng X, Yan J, Garcia FU, Meucci O, Salvino JM, Fatatis A. (2016) Novel Small-Molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells.
Mol Cancer Res, 14 (6): 518-27.
[PMID:27001765]
28. Singh KK, Hughes MD, Chen J, Spector SA. (2005) Genetic polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load.
J Infect Dis, 191 (11): 1971-80.
[PMID:15871132]
29. Teupser D, Pavlides S, Tan M, Gutierrez-Ramos JC, Kolbeck R, Breslow JL. (2004) Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root.
Proc Natl Acad Sci USA, 101 (51): 17795-800.
[PMID:15596719]
Target has curated data in GtoImmuPdb
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License